Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Common Class A [Member]
Additional Paid-in Capital [Member]
[1]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2024 $ 281,091 $ (274,929) $ 265 $ (149) $ 6,278
Balance, shares at Dec. 31, 2024 [1] 378          
Net income (loss) (3,867) (3,867)
Exercise of Class A warrants 11 11
Exercise of Class A warrants, shares [1] 198          
Issuance of Class A shares and warrants 20,722 20,722
Issuance of Class A shares and warrants, shares [1] 814          
Balance at Mar. 31, 2025 301,824 (278,796) 265 (149) 23,144
Balance, shares at Mar. 31, 2025 [1] 1,390          
Balance at Dec. 31, 2024 281,091 (274,929) 265 (149) 6,278
Balance, shares at Dec. 31, 2024 [1] 378          
Net income (loss)           (16,015)
Strategic advisory warrants          
Balance at Sep. 30, 2025 $ 14 301,813 (290,944) 265 (149) 10,999
Balance, shares at Sep. 30, 2025 [1] 173,319          
Balance at Mar. 31, 2025 301,824 (278,796) 265 (149) 23,144
Balance, shares at Mar. 31, 2025 [1] 1,390          
Net income (loss) (3,215) (3,215)
Exercise of pre-funded warrants $ 14 (14)
Exercise of pre-funded warrants, shares [1] 171,929          
Issuance of Class A shares and warrants 3 3
Balance at Jun. 30, 2025 $ 14 301,813 (282,011) 265 (149) 19,932
Balance, shares at Jun. 30, 2025 [1] 173,319          
Net income (loss) (8,933) (8,933)
Strategic advisory warrants          
Balance at Sep. 30, 2025 $ 14 301,813 (290,944) 265 (149) 10,999
Balance, shares at Sep. 30, 2025 [1] 173,319          
Balance at Dec. 31, 2025 $ 6 428,111 (360,509) 265 (149) 67,724
Balance, shares at Dec. 31, 2025 [1] 603,696          
Net income (loss) (18,360) 149 (18,211)
Exercise of pre-funded warrants
Exercise of pre-funded warrants, shares [1] 26,250          
Equity-based compensation 592 592
Exercise of strategic advisory warrants 240 240
Reclassification of accumulated foreign currency translation gain (265) (265)
Balance at Mar. 31, 2026 $ 6 428,943 (378,869) 50,080
Balance, shares at Mar. 31, 2026 [1] 629,946          
Balance at Dec. 31, 2025 $ 6 428,111 (360,509) 265 (149) 67,724
Balance, shares at Dec. 31, 2025 [1] 603,696          
Net income (loss)           (38,611)
Strategic advisory warrants           714
Balance at Sep. 30, 2026 $ 8 429,421 (399,269) 30,160
Balance, shares at Sep. 30, 2026 [1] 761,244          
Balance at Mar. 31, 2026 $ 6 428,943 (378,869) 50,080
Balance, shares at Mar. 31, 2026 [1] 629,946          
Net income (loss) (24,833) (24,833)
Exercise of pre-funded warrants $ 1 (1)
Exercise of pre-funded warrants, shares [1] 33,085          
Exercise of strategic advisory warrants
Exercise of strategic advisory warrants, shares [1] 31,627          
Strategic advisory warrants 236 236
Fractional shares eliminated in connection with reverse stock split
Fractional shares eliminated in connection with reverse stock split, shares [1] (114)          
Balance at Jun. 30, 2026 $ 7 429,178 (403,702) 25,483
Balance, shares at Jun. 30, 2026 [1] 694,544          
Net income (loss) 4,433 4,433
Exercise of pre-funded warrants $ 1 5 6
Exercise of pre-funded warrants, shares [1] 66,700          
Strategic advisory warrants 238 238
Balance at Sep. 30, 2026 $ 8 $ 429,421 $ (399,269) $ 30,160
Balance, shares at Sep. 30, 2026 [1] 761,244          
[1] After giving effect to the Reverse Stock Splits - See Note 8 - Stockholders’ Equity.